TABLE III.
Population | Entire cohort | Total IgE: 1000–2000 IU/mL | Total IgE: >2000 IU/mL | ||||||
---|---|---|---|---|---|---|---|---|---|
n | α-Gal positive (%) | P * | n | α-Gal positive (%) | P * | n | α-Gal positive (%) | P * | |
Ecuador | 599 | 194 (32.4) | NA | 104 | 57 (55) | NA | 89 | 65 (73) | NA |
Reference cohort | |||||||||
Costa Rica | 277 | 13 (5) | <.001 | 28 | 3 (11) | <.001 | 18 | 2 (11) | <.001 |
Northern Sweden | 413 | 1 (0.2) | <.001 | 11 | 0 (0) | <.001 | 6 | 1 (17) | .01 |
NA, Not applicable/available.
Comparison of reference population with Ecuador using Fisher exact test.